Alachua Campus Tour Video
With a sustainable network of high-tech, end-to-end manufacturing facilities across North America, Resilience has become a powerhouse in how...
With a sustainable network of high-tech, end-to-end manufacturing facilities across North America, Resilience has become a powerhouse in how...
Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...
As biopharma companies outsource more specialized activity to CDMOs, successful technology transfer becomes even more integral to project success. To...
by Adam Mendez, Alissa Gordon, and Lee Tessler Originally published on AWS | 27 NOV 2023 We would like to acknowledge the valuable contributions of...
Biomanufacturing safety and efficacy depend on well-controlled, compliant manufacturing processes. Can a virtual model truly give biomanufacturing...
The proliferation of recombinant protein therapies has driven the need for new capacity in the biotherapeutic manufacturing space. Monoclonal...
How Early-Phase Companies Can Future-Proof Their Cell Therapies The following was extracted from a conversation with Eytan Abraham “Q: How should...
The gene therapy and viral vector space has yet to achieve the level of standardization that typifies established modalities, such as monoclonal...